openPR Logo
Press release

Melanoma - Pipeline Review, Industry Analysis, Growth, Trends, and Forecast Report 2017

07-07-2017 01:51 PM CET | Health & Medicine

Press release from: Business Insights Report - MRH

Business Insights Report

Business Insights Report

Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Melanoma - Pipeline Review, H1 2017” to its report offerings. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1217007

Pharmaceutical and Healthcare disease pipeline guide Melanoma - Pipeline Review, H1 2017, provides an overview of the Melanoma (Oncology) pipeline landscape.

Melanoma is a tumor that develops as a result of the malignant transformation of melanocytes. These cells are derived from the neural crest. Melanomas usually occur on the skin but can arise in other locations where neural crest cells migrate, such as in the gastrointestinal tract or brain. It is more common in women than in men. In women, the most common site is the legs and melanomas in men are most common on the back. Unusual moles, sores, lumps, blemishes, markings, or changes in the way an area of the skin looks or feels are sign of melanoma. Treatment includes surgery, radiation and proton therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Melanoma - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Melanoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 20, 105, 120, 7, 214, 29 and 4 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 2, 14, 13, 1, 62 and 14 molecules, respectively.

Melanoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Melanoma (Oncology).
- The pipeline guide reviews pipeline therapeutics for Melanoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Melanoma (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Melanoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Melanoma (Oncology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Melanoma (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Melanoma (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Read Full Report with TOC: http://www.marketresearchhub.com/report/melanoma-pipeline-review-h1-2017-report.html

Table of Contents:
Table of Contents 2
Introduction 11
Melanoma - Overview 12
Melanoma - Therapeutics Development 13
Melanoma - Therapeutics Assessment 71
Melanoma - Companies Involved in Therapeutics Development 103
Melanoma - Drug Profiles 230
Melanoma - Dormant Projects 1675
Melanoma - Discontinued Products 1701
Melanoma - Product Development Milestones 1705
Appendix 1721

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Melanoma - Pipeline Review, Industry Analysis, Growth, Trends, and Forecast Report 2017 here

News-ID: 613079 • Views: 95

More Releases from Business Insights Report - MRH

Global Outdoor Cabinet Heat Exchange Equipments Market Research and Forecast Rep …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Outdoor Cabinet Heat Exchange Equipments Market Research Report 2017” to its report offerings. The report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Outdoor Cabinet Heat Exchange Equipments in these regions, from 2012 to 2022 (forecast). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1220159 The global Outdoor Cabinet Heat Exchange
Global Nichrome Film Resistor Market - Industry Analysis, Growth, Trends, and Fo …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Nichrome Film Resistor Market Research Report 2017” to its report offerings. The report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nichrome Film Resistor in these regions, from 2012 to 2022 (forecast). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1220152 The global Nichrome Film Resistor market is valued at USD
Global Embolization Devices Market - Industry Analysis, Growth, Trends, and Fore …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Embolization Devices Market Research Report 2017” to its report offerings. The report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Embolization Devices in these regions, from 2012 to 2022 (forecast). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1217154 The global Embolization Devices market is valued at USD XX million in
Global Duck Meats Industry Analysis, Size, Share, Growth, Trends, and Forecast R …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Duck Meats Market Research Report 2017” to its report offerings. The report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Duck Meats in these regions, from 2012 to 2022 (forecast). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1217153 The report is segmented into several key Regions, with production, consumption, revenue

All 5 Releases


More Releases for Melanoma

Global Melanoma Drugs Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the
Global Drugs for Melanoma Market Insights, Forecast
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic
12-06-2017 | Health & Medicine
Fact.MR
Melanoma Cancer Diagnostics Market: 7 Key Takeaways
According to a latest market research by fast-growing market research and consulting firm, the global melanoma cancer diagnostics market is poised to grow at over 7% CAGR and surpass US$ 853.5 million in revenues by 2022. Fact.MR’s report forecasts that North America and Europe will remain the most lucrative markets for melanoma cancer diagnostics market globally. Key takeaways from Fact.MR’s report are, Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=57 • The U.S. melanoma cancer
Melanoma Treatment Market – Global Industry Insights, 2025
Melanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular. Cutaneous affects the skin, mucosal affects the mucous membrane in the mouth and nasal passage, and ocular affects the eye. However, early detection of melanoma helps in
Malignant Melanoma Drug Market Malignant Melanoma Clinical Pipeline Report
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Malignant Melanoma 2. Malignant Melanoma Drug Mechanism of Action 3. Global Malignant Melanoma Market Analysis 3.1 Current Market Scenario 3.2 Global Malignant Melanoma Pipeline Overview 4. Global Malignant Melanoma Drug Market Dynamics 4.1 Favorable Market Parameters 4.2 Commercialization Challenges 5. Global Malignant Melanoma Drug Market Future Prospects 6. Global Malignant Melanoma Clinical Pipeline By